ALRDF yields 15384.62% · PFE yields 6.13%● Live data
📍 ALRDF pulled ahead of the other in Year 1
Combined, ALRDF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ALRDF + PFE for your $10,000?
Defence Holdings PLC develops and acquires defence technologies, focusing on AI-enabled systems, cyber-defence, secure communications, autonomous drone systems, and critical infrastructure protection. The company's platform model allows rapid development and deployment of solutions across multiple defence domains, including AI agents for defence operations, information and influence warfare, drone warfare and aggregation, and critical infrastructure defence. The company has a strategic collaboration with Gloucestershire Police to deliver a Proof-of-Value (PoV1) programme for AI-enabled automation of ROVI (Record of Video Interview) and ROTI (Record of Taped Interview) reporting. The company was formerly known as Cassell Capital Plc and changed its name to Defence Holdings PLC in May 2025. The company was incorporated in 2019 and is headquartered in London, the United Kingdom.
Full ALRDF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.